Botulinum Toxin B Is Not an Effective Treatment of Refractory Overactive Bladder

BTX-B had a limited duration of action, with most of its symptomatically beneficial effects wearing off by 10 weeks in most of our patients. The short duration of action for BTX-B suggests it is unlikely to gain widespread use in the treatment of DO.